Ocugen (OCGN) Capital Leases (2018 - 2019)

Ocugen (OCGN) posted Capital Leases of $17339.0 for Q3 2019, down 48.58% on a QoQ basis from $33720.0 in Q4 2018.

Ocugen (OCGN) Capital Leases (2018 - 2019) Analysis & Trends

Ocugen's Capital Leases history runs 2 years deep, the most recent figure standing at $17339.0 for Q3 2019.

Quarterly Capital Leases changed N/A year-over-year to $17339.0 in Q3 2019, while the trailing twelve-month figure through Sep 2019 was $17339.0 (changed N/A YoY) and the FY2018 annual result came in at $33720.0, changed N/A from the prior year.
Capital Leases was $17339.0 for Q3 2019 at Ocugen, down from $33720.0 in the prior quarter.
Across five years, Capital Leases topped out at $33720.0 in Q4 2018 and bottomed at $17339.0 in Q3 2019.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn
4	NuCana	279.75 Bn	279.75 Bn	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-
10	Ocugen	63.79 Mn	63.79 Mn	-

Historic Data

Download Data

Date	Value
Sep 30, 2019	17,339.00
Dec 31, 2018	33,720.00